Nirmal Nidaan And Diagnostic Research Centre Profile
Key Indicators
- Authorised Capital ₹ 2.40 M
as on 20-12-2024
- Paid Up Capital ₹ 0.10 M
as on 20-12-2024
- Company Age 33 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 13.92%
(FY 2022)
- Profit 92.92%
(FY 2022)
- Ebitda 23.92%
(FY 2022)
- Net Worth -1.66%
(FY 2022)
- Total Assets -2.27%
(FY 2022)
About Nirmal Nidaan And Diagnostic Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.40 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vaishali Gore, Vinay Gore, Sameer Gore, and One other member serve as directors at the Company.
- CIN/LLPIN
U85195KA1991PTC011830
- Company No.
011830
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Apr 1991
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Dharwad, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nirmal Nidaan And Diagnostic Research Centre?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Gore  | Managing Director | 03-Apr-1991 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vaishali Gore | Director | 03-Apr-1991 | Current |
| Sameer Gore | Director | 23-Jul-2015 | Current |
| Jui Gore | Director | 23-Jul-2015 | Current |
Financial Performance of Nirmal Nidaan And Diagnostic Research Centre.
Nirmal Nidaan And Diagnostic Research Centre Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.92% increase. The company also saw a substantial improvement in profitability, with a 92.92% increase in profit. The company's net worth dipped by a decrease of 1.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nirmal Nidaan And Diagnostic Research Centre?
In 2019, Nirmal Nidaan And Diagnostic Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nirmal Nidaan And Diagnostic Research Centre?
Unlock and access historical data on people associated with Nirmal Nidaan And Diagnostic Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nirmal Nidaan And Diagnostic Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nirmal Nidaan And Diagnostic Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
